Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in miniature horses given endotoxin.

This research article explores the effects of a monoclonal antibody for equine tumor necrosis factor-alpha on various molecular and metabolic responses in miniature horses injected with a bacterial endotoxin. The findings showed that horses treated with the antibody displayed significantly lower levels of interleukin 6, lactate, and prostacyclin metabolite after endotoxin administration, with no changes observed in thromboxane production.

Methodology

• The experiment involved ten Miniature Horses. Each horse was given a dose of lipopolysaccharide (LPS), an endotoxin derived from Escherichia coli O55:B5.
• The dosage of LPS given was proportional to the body weight of the horse, 0.25 microgram/kg.
• A monoclonal antibody (MAB) against equine tumor necrosis factor-alpha (EqTNF), a molecule involved in inflammatory pathways, was administered to half of the horses.
• The other half were given an isotype-matched MAB as a control. The antibody was administered intravenously five minutes before LPS injection.
• Blood samples were collected 20 minutes before and several times up to 24 hours after the LPS administration to measure the concentrations of various substances.

Measured Parameters

• Interleukin 6 (IL-6) bioactivity was measured with an IL-6 dependent cell line (B9). IL-6 is a cytokine, a type of protein that plays a crucial role in cell signaling during immune responses.
• Eicosanoid activities were evaluated by enzyme immunoassay. Eicosanoids are signaling molecules made by the enzymatic or non-enzymatic oxidation of arachidonic acid or other polyunsaturated fatty acids that are similar to arachidonic acid.
• Plasma lactate concentration was also determined enzymatically. Lactate, the ionized form of lactic acid, often accumulates in blood as a result of oxygen depletion in tissues.

Results

• The horses treated with EqTNF MAB had significantly lower peak mean values for IL-6, lactate, and the prostacyclin metabolite 6-keto-PGF1 alpha. This suggests a possible role of TNF in mediating these responses.
• No differences in thromboxane A2 metabolite production, another eicosanoid, were observed between the treated and control group. This indicates the TNF blockade doesn’t affect this particular eicosanoid response.

Conclusion

• The researchers concluded that tumor necrosis factor mediates the production of IL-6, lactate, and prostacyclin responses in Miniature Horses given LPS but does not have an effect on thromboxane production. This research could facilitate the development of therapeutic strategies for managing inflammatory conditions in horses.